๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shangqiu
Clinical trial register · China

Clinical Trials in Shangqiu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shangqiu

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
NCT07800572Acute Ischemic Stroke
Capital Medical University
Phase 2
204
Anyang, Beijing, Huzhou, Jiuquan, Lishui, Shangqiu, Suzhou, Taizhou
2026-09-06
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.
NCT07774143Esophageal Varices
The First Affiliated Hospital of Zhengzhou University
Not applicable
339
Anyang, Jiaozuo, Kaifeng, Luohe, Luoyang, Nanyang, Sanmenxia, Shangqiu
2026-06-20
Recruiting
Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
NCT07600983Streptococcus Pneumoniae Infection
CanSino Biologics Inc.
Phase 1/2
854
Shangqiu, Xuchang
2026-05-24
Active, closed
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233Acute Ischemic Stroke
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis, Haemophilus Influenzae Type B Infection
CanSino Biologics Inc.
Phase 1
260
Shangqiu
2025-12-19
Not yet open
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib๏ผšA Prospective, Single-arm, Multicenter, Observational Study
NCT07180459Carcinoma, Hepatocellular Carcinoma
Xuhua Duan
Observational
118
Guiyang, Haikou, Kaifeng, Luohe, Luoyang, Nanyang, Shangqiu, Zhoukou
2025-10-10
Not yet open
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
NCT07156617Hepatocellular Carcinoma (HCC)
Xuhua Duan
Observational
2,000
Haikou, Xingtai, Dengzhou, Jiaozuo, Kaifeng, Luoyang, Shangqiu, Zhengzhou
2025-10-01
Recruiting
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
NCT07694648Respiratory Tract Infections (RTI), Respiratory Syndrome, Acute, Severe, Acute Respiratory Infections (ARIs)
Huashan Hospital
Observational
2,398
Beijing, Guangzhou, Zhuhai, Shijiazhuang, Harbin, Jiamusi, Shangqiu, Zhengzhou
2025-09-01
Not yet open
A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC
NCT06823050Hepatocellular Carcinoma
Xuhua Duan
Observational
59
Dengzhou, Jiaozuo, Kaifeng, Luoyang, Shangqiu, Zhengzhou, Zhoukou
2025-03-01
Active, closed
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
NCT06642558Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company
Phase 1/2
522
Shangqiu
2024-11-13
Recruiting
Mobile Applet for Weight Management in Obese Heart Failure Patients
NCT06455878Heart Failure, Overweight and Obesity, Weight Loss, Heart Failure With Reduced Ejection Fraction
Heart Health Research Center
Not applicable
830
Beijing, Guangzhou, Langfang, Jixi, Luoyang, Shangqiu, Xinyang, Zhengzhou
2024-06-06
Recruiting
Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
NCT06422052Helicobacter Pylori Infection, Dyspepsia
Shanghai Jiao Tong University School of Medicine
Observational
2,242
Chongqing, Xiamen, Wuwei, Qinzhou, Luoyang, Shangqiu, Xuchang, Wuhan
2024-03-11
Active, closed
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
NCT05621655Rotavirus Infections, Rotavirus Gastroenteritis
MAXVAX Biotechnology Limited Liability Company
Phase 2
1,512
Shangqiu
2023-01-08
Active, closed
Prognostic Value of the AMR Measured After PPCI in STEMI Patients
NCT05653765Coronary Heart Disease, ST Elevation Myocardial Infarction
Henan Institute of Cardiovascular Epidemiology
Observational
2,663
Shangqiu, Xinxiang, Yongcheng, Zhengzhou, Shanghai
2022-12-20
Active, closed
Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
NCT04946734PFO - Patent Foramen Ovale, Migraine
Guangdong Provincial People's Hospital
Phase 3
440
Xiamen, Guangzhou, Huizhou, Jiangmen, Shenzhen, Zhanjiang, Nanning, Shangqiu
2021-08-12
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shangqiu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Shangqiu.

How many clinical trials are recruiting in Shangqiu?

7 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shangqiu), 15 studies
PhaseStudiesRecruitingShare
Observational6240%
Not applicable2213.3%
Phase 12113.3%
Phase 1/22113.3%
Phase 22113.3%
Phase 3106.7%

Most active sponsors

Lead sponsors with the most studies (Shangqiu)
Lead sponsorStudiesRecruiting
Xuhua Duan30
CanSino Biologics Inc.22
Capital Medical University21
MAXVAX Biotechnology Limited Liability Company20
Guangdong Provincial People's Hospital10
Heart Health Research Center11
Henan Institute of Cardiovascular Epidemiology10
Huashan Hospital11
Shanghai Jiao Tong University School of Medicine11
The First Affiliated Hospital of Zhengzhou University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.